Pharmaceuticals

Global and China Drugs for Treatment of Prostate Cancer Research Report 2015 to 2021

  • QYR603824
  • 180 Pages
  • June 2016
  • Pharmaceuticals
The global Drugs for Treatment of Prostate Cancer market was valued at USD 43.47 Billion in 2015, and is projected to reach USD 52.16 Billion by 2021, at a CAGR of 9.99% between 2016 and 2021. The market is projected witness significant growth in the coming years, owing to the aging population increase, increased incidence and development of new drugs

This report studies Drugs for Treatment of Prostate Cancer in Global market, including Triptorelin, Leuprorelin, Flutamide Tablets, Goserelin, Bicalutamide Tablets, Bicalutamide Capsules, Estramustine Phosphate Capsules, Mitoxantrone, Zytiga and Xtandi, focuses on price, sales, revenue of each type in global. This report also focuses on the sales (consumption), production, import and export of Drugs for Treatment of Prostate Cancer in America, Established ROW, Western Europe, Emerging Markets, Russia and China, forecast to 2021, from 2015.And Zytiga took up 51.33% market share in 2015.

On basis of segments by Types, this report focuses on price, sales, revenue and growth rate of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers.

On basis of segments by manufacturers, this report focuses on the sales, price of each type, average price of Drugs for Treatment of Prostate Cancer, revenue and market share, for key manufacturers. The main manufacturers as follows: IPSEN, Ferring Pharmaceuticals, Takeda Pharmaceutical Company Limited, Schering-Plough Canada, S.C.SINDAN-PHARMA S.R.L., AstraZeneca, Corden Pharma GmbH, Shanxi Zhendong Pharmaceutical, Pfizer, Johnson, Astellas and so on.

On basis of segments by regions, this report focuses on the sales (consumption), production, import and export of Drugs for Treatment of Prostate Cancer in America, Established ROW, Western Europe, Emerging Markets, Russia and China.

On basis of segments by applications, this report focuses on consumption and growth rate of Drugs for Treatment of Prostate Cancer in major applications.

With 180 pages, 216 charts and eight chapters, to display the market present situation and future, clearly and deeply.


Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global Cervical Cancer Diagnostic Market (Types, Age group and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Cervical cancer refers to a malignancy of cervical cells. Vaginal bleeding is the most common symptom of this kind of cancer; however, in certain cases, no symptoms are seen until ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Telemedicine Market (Service, Technology, Application and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Telemedicine overcomes the barrier of distance by providing clinical health care through information technology and telecommunication. It makes health service more accessible, particularly in isolated rural areas where medical care is not consistently available primarily due to the location.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Radiopharmaceuticals Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Radiopharmaceutical is a radioactive pharmaceutical agent which is used diagnostic or therapeutic procedures. A radiopharmaceutical is made up of two components that are drug component and radioactive component. This radioactive ...

July 2017  |   Price:$ 4995    | Pre Book Price:$ 4995

Read More >>

Global Hemophilia Treatment Market (Type, Medicine and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Hemophilia is a hereditary genetic disorder which impairs body ability to control coagulation or blood clotting. In this disease, clotting factors control bleeding from a broken vessel is deficient; therefore, ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Organ Transplant Immunosuppressant Drugs Market (Therapeutics, Commercialized Products and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Organ transplant immunosuppressant drugs are the category of drugs which are administered to minimize the chances of organ rejection after transplantation. When a person undergoes any transplantation, the body recognizes ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

RNA-Based Therapeutics Asia-Pacific Market Research Report, 2014 - 2021

The RNA-based therapeutics involves broad range of the RNA-based technologies, which help the patients to diagnose or treat various chronic diseases. The RNA-based therapeutics play a crucial role in providing ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

2017 © Copyright Big Market Research

View Pricing >>